Mass. initiative aims to reduce ED overcrowding

SmartBrief sent this email to their subscribers on June 29, 2024.

Drug combo shows promise for some early breast cancers | Mass. initiative aims to reduce ED overcrowding | Child mental health center makes care more accessible

Created for [email protected] | Web Version

June 28, 2024

CONNECT WITH SMARTBRIEF

A news roundup for health care executives

Top Story

Drug combo shows promise for some early breast cancers

Some early-stage breast cancer patients may be able to stay cancer-free with a regimen of Kadcyla, an immunotherapy and chemotherapy drug combination manufactured by Genentech, researchers reported in the Journal of Clinical Oncology. Stage 1 HER2-positive breast cancer patients who received the combo experienced "outstanding long-term outcomes, making it a reasonable treatment approach for select patients," said researcher Dr. Sara Tolaney of the Dana-Farber Cancer Institute.

Full Story: HealthDay News (6/28)

Health Care Leadership & Innovation

Mass. initiative aims to reduce ED overcrowding

(Pixabay)

Massachusetts health officials announced a 90-day strategy to direct some nonemergency patients in the eastern part of the state to urgent care centers when possible, to lessen summertime emergency department volume. Insurers, urgent care organizations and health care associations have expressed support for the initiative.

Full Story: WBTS-TV (Boston) (6/28)

Child mental health center makes care more accessible

A new behavioral health walk-in clinic for pediatric patients is set to open July 15 in Rochester, N.Y. The Brighter Days Pediatric Mental Health Urgent Care Center, a project of Golisano Children's Hospital, is the region's first of its kind and will serve patients up to age 18. "Everything we do at the clinic will be family-centered, with the goal of providing immediate and safe mental health care so that children can avoid trips to the emergency room and long wait times for outpatient services," said GCH psychiatrist-in-chief Dr. Michael Scharf.

Full Story: Spectrum News (6/26), WXXI-TV (Rochester, N.Y.) (6/27)

Legislation, Policy & Regulation

CDC: People 6 months and up should get new COVID-19 shots

(Pixabay)

The CDC announced this week that all Americans aged six months and older should get an updated COVID-19 vaccine targeting prevailing strains of the virus this autumn. Manufacturers including Pfizer, Moderna and Novavax are working on the vaccines. Numbers of infections are on the rise in at least 39 US states and territories.

Full Story: The New York Times (6/27)

FDA issues draft guidance for clinical trial diversity

The FDA is accepting comments on draft guidance suggesting ways that drugmakers and medical device makers can improve diversity in clinical trial participant pools. Goals for a "diversity action plan" should consider the estimated prevalence of the target disease, and the agency will require most makers of new drugs and devices to submit clinical trial diversity plans.

Full Story: Reuters (6/26)

CDC data break down who gets opioid use disorder meds

In 2022, 25.1% of adults with opioid use disorder received medication to treat it, 42.7% did not believe they needed medication and 30% were treated without medication, according to CDC data published in the agency's Morbidity and Mortality Weekly Report. Treatment varied by race, gender and age.

Full Story: HealthDay News (6/28)

Free eBooks and Resources

Free eBooks and resources brought to you by our sponsors

Trends & Technology

Many new drugs in development for Alzheimer's disease

(Pixabay)

Recently developed medications for Alzheimer's disease have not lived up to expectations, spurring researchers to look elsewhere for answers. An analysis in the journal Alzheimer's & Dementia: Translational Research & Clinical Interventions found that 127 Alzheimer's medications were being studied in 164 clinical trials at the start of 2024, with about three-quarters aimed at modifying disease state rather than just treating symptoms.

Full Story: Axios (6/28)

Remote CGM can help patients manage diabetes

Remote continuous glucose monitoring can help diabetes patients and clinicians better manage treatment and implement appropriate lifestyle changes, researchers reported at the American Diabetes Association 84th Scientific Sessions. One study found that 100% of patients using a remote CGM platform viewed it favorably, and 95% said they would continue using it post-study. Another study compared remote and manual CGM methods.

Full Story: Drug Topics (6/27)

SmartBreak: Question of the Day

"Double, double, toil and trouble; Fire burn, and cauldron bubble!" When the Globe Theater burned down in 1613, what Shakespeare play was being staged?

"All's Well That Ends Well"

"Henry VIII"

"Macbeth"

"The Tempest"

Sharing SmartBrief for Health Care Leaders with your network keeps the quality of content high and these newsletters free.

Help Spread the Word

Or copy and share your personalized link:

smartbrief.com/hcleaders/?referrerId=ojmWxpWGsv

Who Said It?

Isn't it nice to think that tomorrow is a new day with no mistakes in it yet?

L. M. Montgomery or Donald Sutherland

Check your answer here.

SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio

Text-only version of this email

Drug combo shows promise for some early breast cancers | Mass. initiative aims to reduce ED overcrowding | Child mental health center makes care more accessible Created for [email protected] | Web Version June 28, 2024 CONNECT WITH SMARTBRIEF LinkedIn Facebook X SmartBrief for Health Care Leaders A news roundup for health care executivesSIGN UP ⋅ SHARE Top Story Drug combo shows promise for some early breast cancers Some early-stage breast cancer patients may be able to stay cancer-free with a regimen of Kadcyla, an immunotherapy and chemotherapy drug combination manufactured by Genentech, researchers reported in the Journal of Clinical Oncology. Stage 1 HER2-positive breast cancer patients who received the combo experienced "outstanding long-term outcomes, making it a reasonable treatment approach for select patients," said researcher Dr. Sara Tolaney of the Dana-Farber Cancer Institute. Full Story: HealthDay News (6/28) LinkedIn X Facebook Email Health Care Leadership & Innovation Mass. initiative aims to reduce ED overcrowding Mass. initiative aims to reduce ED overcrowding (Pixabay) Massachusetts health officials announced a 90-day strategy to direct some nonemergency patients in the eastern part of the state to urgent care centers when possible, to lessen summertime emergency department volume. Insurers, urgent care organizations and health care associations have expressed support for the initiative. Full Story: WBTS-TV (Boston) (6/28) LinkedIn X Facebook Email Child mental health center makes care more accessible A new behavioral health walk-in clinic for pediatric patients is set to open July 15 in Rochester, N.Y. The Brighter Days Pediatric Mental Health Urgent Care Center, a project of Golisano Children's Hospital, is the region's first of its kind and will serve patients up to age 18. "Everything we do at the clinic will be family-centered, with the goal of providing immediate and safe mental health care so that children can avoid trips to the emergency room and long wait times for outpatient services," said GCH psychiatrist-in-chief Dr. Michael Scharf. Full Story: Spectrum News (6/26), WXXI-TV (Rochester, N.Y.) (6/27) LinkedIn X Facebook Email Legislation, Policy & Regulation CDC: People 6 months and up should get new COVID-19 shots CDC: People 6 months and up should get new COVID-19 shots (Pixabay) The CDC announced this week that all Americans aged six months and older should get an updated COVID-19 vaccine targeting prevailing strains of the virus this autumn. Manufacturers including Pfizer, Moderna and Novavax are working on the vaccines. Numbers of infections are on the rise in at least 39 US states and territories. Full Story: The New York Times (6/27) LinkedIn X Facebook Email FDA issues draft guidance for clinical trial diversity The FDA is accepting comments on draft guidance suggesting ways that drugmakers and medical device makers can improve diversity in clinical trial participant pools. Goals for a "diversity action plan" should consider the estimated prevalence of the target disease, and the agency will require most makers of new drugs and devices to submit clinical trial diversity plans. Full Story: Reuters (6/26) LinkedIn X Facebook Email CDC data break down who gets opioid use disorder meds In 2022, 25.1% of adults with opioid use disorder received medication to treat it, 42.7% did not believe they needed medication and 30% were treated without medication, according to CDC data published in the agency's Morbidity and Mortality Weekly Report. Treatment varied by race, gender and age. Full Story: HealthDay News (6/28) LinkedIn X Facebook Email Free eBooks and Resources Free eBooks and resources brought to you by our sponsors * Marketing Technology Planning Guide * How to Create Lasting Change * How to Introduce Yourself * On the Radar: AKATI Sekurity's award-winning managed security services * Course: Introduction to Getting Things Done Trends & Technology Many new drugs in development for Alzheimer's disease Many new drugs in development for Alzheimer's disease (Pixabay) Recently developed medications for Alzheimer's disease have not lived up to expectations, spurring researchers to look elsewhere for answers. An analysis in the journal Alzheimer's & Dementia: Translational Research & Clinical Interventions found that 127 Alzheimer's medications were being studied in 164 clinical trials at the start of 2024, with about three-quarters aimed at modifying disease state rather than just treating symptoms. Full Story: Axios (6/28) LinkedIn X Facebook Email Remote CGM can help patients manage diabetes Remote continuous glucose monitoring can help diabetes patients and clinicians better manage treatment and implement appropriate lifestyle changes, researchers reported at the American Diabetes Association 84th Scientific Sessions. One study found that 100% of patients using a remote CGM platform viewed it favorably, and 95% said they would continue using it post-study. Another study compared remote and manual CGM methods. Full Story: Drug Topics (6/27) LinkedIn X Facebook Email SmartBreak: Question of the Day "Double, double, toil and trouble; Fire burn, and cauldron bubble!" When the Globe Theater burned down in 1613, what Shakespeare play was being staged? Vote"All's Well That Ends Well" Vote"Henry VIII" Vote"Macbeth" Vote"The Tempest" Sharing SmartBrief for Health Care Leaders with your network keeps the quality of content high and these newsletters free. Help Spread the Word SHARE Or copy and share your personalized link: smartbrief.com/hcleaders/?referrerId=ojmWxpWGsv Who Said It? Isn't it nice to think that tomorrow is a new day with no mistakes in it yet? L. M. Montgomery or Donald Sutherland Check your answer here. LinkedIn X Facebook Email SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio Sign Up | | Advertise with SmartBrief | CONTACT US: FEEDBACK | ADVERTISE SmartBrief Future Copyright © 2024 SmartBrief. All Rights Reserved. A division of Future US LLC Full 7th Floor, 130 West 42nd Street, New York, NY, 10036.

Show all